Brief: Fluidigm Stockholders Approve $250 Million Strategic Capital Infusion

Standard BioTools

01/04/2022 21:09

April 1 (Reuters) - Fluidigm Corp  FLDM.O :
    * FLUIDIGM STOCKHOLDERS APPROVE $250 MILLION STRATEGIC
CAPITAL
INFUSION
    * FLUIDIGM CORP - UNDER TERMS OF AGREEMENT, CASDIN AND
VIKING WILL
PURCHASE $225 MILLION IN AGGREGATE PRINCIPAL AMOUNT OF
CONVERTIBLE PREFERRED SHARES

Source text for Eikon:  ID:nGNX1mb6f4 
Further company coverage:  FLDM.O 

 ((Reuters.Briefs@thomsonreuters.com;))